The C3 RFA that was announced on September 15, 2016 is drawing to a close, and we request that all submissions, which we have been receiving on a rolling basis, be sent to Dr. Jennifer Levy no later than June
C3 supports generation of new LGMD2A disease model for research
C3 is excited to announce that we are funding a research project with Dr. Cathleen Lutz, Director of the Rare and Orphan Disease Center at The Jackson Laboratory in Bar Harbor, Maine. Dr. Lutz works with researchers and disease foundations
C3 Lends Support to New Initiative in Genetic Testing for LGMD2A Patients
Coalition to Cure Calpain 3 is excited to announce that we are funding the MYO-SEQ project at the John Walton Muscular Research Centre at Newcastle University (UK). We are partnering with several patient organizations and biopharmaceutical companies to support this
Welcome!
Welcome to C3’s ‘News’ page! C3 will use this space to provide updates on the latest happenings at C3, as well as in the limb girdle muscular dystrophy type 2A (LGMD2A)/calpainopathy research field. Please re-visit this page often for continued
English
አማርኛ
العربية
简体中文
繁體中文
Dansk
Nederlands
Français
Deutsch
עִבְרִית
हिन्दी
Italiano
日本語
ភាសាខ្មែរ
한국어
كوردی
मराठी
Norsk bokmål
Polski
Português
ਪੰਜਾਬੀ
Русский
Español
Svenska
தமிழ்
తెలుగు
Türkçe